Brincidofovir: all 22 studies that test it

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot StudyRecruitingNCT07511049Phase 2
• A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCTRecruitingNCT07387367Phase 3
• The AdAPT Trial; Adenovirus After Allogeneic Pediatric TransplantationTerminatedNCT03339401Phase 2Results posted
• A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus DiseaseTerminatedNCT02439970Phase 3Results posted
• A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of CytomegalovirusTerminatedNCT02439957Phase 3Results posted
• Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus InfectionCompletedNCT02087306Phase 3Results posted
• A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT RecipientsCompletedNCT01769170Phase 3Results posted
• Phase 2 Study to Evaluate Brincidofovir for the Prevention of Adenovirus DiseaseCompletedNCT01241344Phase 2Results posted
• Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA VirusesCompletedNCT01143181Phase 3Results posted
• Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant RecipientsCompletedNCT00942305Phase 2Results posted
• CMX001 in Post-transplant Patients With BK Virus ViruriaCompletedNCT00793598Phase 1/2Results posted
• A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell LymphomaSuspendedNCT06761677Phase 1/2
• Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy AdultsCompletedNCT05935917Phase 1
• Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney TransplantationTerminatedNCT05511779Phase 2
• Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy SubjectsCompletedNCT05391724Phase 1
• A Phase 2a Study of IV BCV in Subjects With Adenovirus InfectionCompletedNCT04706923Phase 2
• Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy SubjectsCompletedNCT04542252Phase 1
• An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of EbolaWithdrawnNCT04268966Phase 2
• Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus ViremiaWithdrawnNCT03532035Phase 2
• An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus DiseaseWithdrawnNCT02271347Phase 2
• A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).CompletedNCT01563328Phase 1
• Comparative Bioavailability and Effect of Food on CMX001 in Healthy VolunteersCompletedNCT00780182Phase 1

← Brincidofovir overview